[go: up one dir, main page]

NO963307L - Karbamoylmetylureaderivater - Google Patents

Karbamoylmetylureaderivater

Info

Publication number
NO963307L
NO963307L NO963307A NO963307A NO963307L NO 963307 L NO963307 L NO 963307L NO 963307 A NO963307 A NO 963307A NO 963307 A NO963307 A NO 963307A NO 963307 L NO963307 L NO 963307L
Authority
NO
Norway
Prior art keywords
optionally substituted
receptors
cck
substituted phenyl
heterocyclic group
Prior art date
Application number
NO963307A
Other languages
English (en)
Other versions
NO963307D0 (no
Inventor
Sanji Hagishita
Susumu Kamata
Yasushi Murakami
Nobuhiro Haga
Yasunobu Ishihara
Toshiro Konoike
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO963307D0 publication Critical patent/NO963307D0/no
Publication of NO963307L publication Critical patent/NO963307L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

En forbindelse med formel (I): Q ¿R2 NHR, hvori R! er en hydrogenatom eller lavere alkyl; R2 er en lavere alkoksy-, lavere alkylamino-, lavere sykloalkyl-, eventuelt substituert fenyl- eller eventuelt substituert heterosyklisk gruppe; R3 er en eventuelt substituert fenylgruppe; R4 er en eventuelt substi- tuert fenyl-, eventuelt substituert sykloalkyl-, eventuelt substituert alkyl- eller eventuelt substituert heterosyklisk gruppe, eller et farma- søytisk akseptabelt salt derav, som har en høy affinitet for gastrinreseptorer og/eller CCK-B-reseptorer, men ikke for CCK-A-reseptorer, og som er anvendelig for behandling av sykdommer forbundet med gastrinreseptorer og/eller CCK-B- reseptorer uten å indusere bivirk- ningene forbundet med CCK-A-reseptorer.
NO963307A 1994-02-09 1996-08-08 Karbamoylmetylureaderivater NO963307L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1518994 1994-02-09
JP24155594 1994-10-05
PCT/JP1995/000161 WO1995021856A1 (en) 1994-02-09 1995-02-07 Carbamoylmethylurea derivative

Publications (2)

Publication Number Publication Date
NO963307D0 NO963307D0 (no) 1996-08-08
NO963307L true NO963307L (no) 1996-10-09

Family

ID=26351304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963307A NO963307L (no) 1994-02-09 1996-08-08 Karbamoylmetylureaderivater

Country Status (17)

Country Link
US (1) US5739162A (no)
EP (1) EP0739903B1 (no)
CN (1) CN1145074A (no)
AT (1) ATE212356T1 (no)
AU (1) AU691565B2 (no)
BR (1) BR9506763A (no)
CA (1) CA2181986A1 (no)
DE (1) DE69525145T2 (no)
ES (1) ES2171531T3 (no)
FI (1) FI963122A7 (no)
HU (1) HU219913B (no)
MX (1) MX9603171A (no)
NO (1) NO963307L (no)
PT (1) PT739903E (no)
RU (1) RU2134684C1 (no)
TW (1) TW294653B (no)
WO (1) WO1995021856A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
KR19990036236A (ko) * 1995-08-07 1999-05-25 시오노 요시히코 카바모일메틸우레아 유도체의 제조 방법
AU2014290618B2 (en) * 2013-07-16 2018-04-05 Allergan, Inc. Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
ES2052372T3 (es) * 1990-02-09 1994-07-01 Rhone Poulenc Rorer Sa N-fenil n-acetamido glicinamidas su preparacion y los medicamentos que las contienen.
FR2667864B2 (fr) * 1990-03-07 1994-08-05 Rhone Poulenc Sante Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
FR2659334B1 (fr) * 1990-03-07 1992-05-15 Rhone Poulenc Sante Derives de n-phenyl glycinamide, leur preparation et les medicaments les contenant.
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.

Also Published As

Publication number Publication date
DE69525145D1 (en) 2002-03-14
NO963307D0 (no) 1996-08-08
BR9506763A (pt) 1997-10-07
US5739162A (en) 1998-04-14
EP0739903B1 (en) 2002-01-23
WO1995021856A1 (en) 1995-08-17
CN1145074A (zh) 1997-03-12
PT739903E (pt) 2002-05-31
ATE212356T1 (de) 2002-02-15
FI963122A0 (fi) 1996-08-09
DE69525145T2 (de) 2002-08-29
FI963122L (fi) 1996-08-09
TW294653B (no) 1997-01-01
EP0739903A4 (en) 1998-07-08
EP0739903A1 (en) 1996-10-30
AU691565B2 (en) 1998-05-21
AU1590595A (en) 1995-08-29
FI963122A7 (fi) 1996-08-09
HU219913B (hu) 2001-09-28
ES2171531T3 (es) 2002-09-16
RU2134684C1 (ru) 1999-08-20
CA2181986A1 (en) 1995-08-17
MX9603171A (es) 1997-03-29
HUT74950A (en) 1997-03-28
HU9602187D0 (en) 1996-10-28

Similar Documents

Publication Publication Date Title
NZ336332A (en) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
DE69327541D1 (en) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
MY117021A (en) Parasiticidal pyrazoles
GB9218552D0 (en) Heterocyclic compounds
DE3789967D1 (de) Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems.
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
ES476343A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
NO944934L (no) Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom
MY131641A (en) Indoline derivatives, process of preparation and use
IL97180A0 (en) N-phenyl-n-acetamidoglycinamides,their preparation and medicaments containing them
NO943100L (no) Forbindelser for anvendelse i kontrastmidler for radiografi
DK429089D0 (da) Alkylbenzylaminer
GR3001356T3 (en) 3-vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments
NO163735C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkyl-beta-carboliner.
NO963307L (no) Karbamoylmetylureaderivater
ZA93996B (en) Pyrrolidine compounds, processes for preparing them and pharmaceutical compositions containing them.
AU1201195A (en) Novel benzodiazepine derivative
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
BG103414A (en) N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments
NO944909L (no) Fremgangsmåter for inhibering av mannlig infertilitet
NO940321L (no) Forbindelser med angiotensin II - antagonistisk aktivitet
ES2056025A1 (es) Nuevos derivados de indol.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application